MyCartis Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Out of Business

MyCartis General Information

Description

Developer of immuno-diagnostic equipment designed to focus on oncology and in particular immuno-oncology. The company's equipment leverages quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real time, enabling clinical researchers to get accurate medical guidance with any sample.

Contact Information

Formerly Known As
Pronota
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Industriepark Zwijnaarde 7C
  • Zwijnaarde
  • 9052 Ghent
  • Belgium
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Industriepark Zwijnaarde 7C
  • Zwijnaarde
  • 9052 Ghent
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MyCartis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 16-Mar-2021 Completed Out of Business
2. Accelerator/Incubator Completed Generating Revenue
1. Early Stage VC 04-Sep-2014 $19.9M $19.9M Completed Generating Revenue
To view MyCartis’s complete valuation and funding history, request access »

MyCartis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immuno-diagnostic equipment designed to focus on oncology and in particular immuno-oncology. The company's
Diagnostic Equipment
Ghent, Belgium
51 As of 2016

Fremont, CA
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MyCartis Competitors (17)

One of MyCartis’s 17 competitors is BioGenex Laboratories, a Corporation company based in Fremont, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioGenex Laboratories Corporation Fremont, CA
Sera Prognostics Formerly VC-backed Salt Lake City, UT
Foundation Medicine Formerly VC-backed Boston, MA
RareCyte Venture Capital-Backed Seattle, WA
Asuragen Formerly VC-backed Austin, TX
You’re viewing 5 of 17 competitors. Get the full list »

MyCartis Patents

MyCartis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3512633-A1 Prefilled cartridge Inactive 12-Oct-2016
US-20200290038-A1 Prefilled cartridge Inactive 12-Oct-2016
WO-2018069056-A1 Prefilled cartridge Inactive 12-Oct-2016
WO-2018065417-A1 Method for measuring avidity or functional affinity Inactive 03-Oct-2016
AU-2016347740-A1 Use of cd146 as a marker of the vascular wall tension Inactive 06-Nov-2015 G01N33/575
To view MyCartis’s complete patent history, request access »

MyCartis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MyCartis FAQs

  • When was MyCartis founded?

    MyCartis was founded in 2014.

  • Where is MyCartis headquartered?

    MyCartis is headquartered in Ghent, Belgium.

  • What is the size of MyCartis?

    MyCartis has 51 total employees.

  • What industry is MyCartis in?

    MyCartis’s primary industry is Diagnostic Equipment.

  • Is MyCartis a private or public company?

    MyCartis is a Private company.

  • What is MyCartis’s current revenue?

    The current revenue for MyCartis is .

  • How much funding has MyCartis raised over time?

    MyCartis has raised $19.9M.

  • Who are MyCartis’s competitors?

    BioGenex Laboratories, Sera Prognostics, Foundation Medicine, RareCyte, and Asuragen are some of the 17 competitors of MyCartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process